SCHEMBL354474

SCHEMBL354474

CCOC(=O)C1C(C)=C1C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.48
HSD17B10 Q99714 2/20 0.46
LMNA P02545 2/20 0.46
GAA P10253 3/20 0.43
ALOX15 P16050 1/20 0.43
MGAM O43451 1/20 0.43
SI P14410 1/20 0.43
MGAM2 Q2M2H8 1/20 0.43
SOAT1 P35610 1/20 0.43
KDM4E B2RXH2 6/20 0.43
HTT P42858 1/20 0.43
TSHR P16473 1/20 0.42
POLB P06746 1/20 0.42
MEN1 O00255 1/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
KMT2A Q03164 1/20 0.41
CYP4F2 P78329 1/20 0.41
CYP4A11 Q02928 1/20 0.41
TRPA1 O75762 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6155679 0.82 ALDH1A1 (0.42) ALDH1A1HSD17B10LMNAGAAALOX15
SCHEMBL14441609 0.80 ALDH1A1 (0.44) ALDH1A1HSD17B10LMNAGAAKDM4E
SCHEMBL16625947 0.80 TSHR (0.39) ALDH1A1HSD17B10LMNAGAAKDM4E
SCHEMBL12994228 0.77 ALDH1A1 (0.53) ALDH1A1HSD17B10LMNAGAAALOX15
SCHEMBL2653688 0.74 TSHR (0.53) ALDH1A1LMNAGAAKDM4ETSHR
SCHEMBL220343 0.74 ALDH1A1 (0.50) ALDH1A1HSD17B10GAAKDM4EHTT
SCHEMBL18382542 0.74
SCHEMBL3630275 0.74 ALDH1A1 (0.56) ALDH1A1HSD17B10LMNAGAAMGAM
SCHEMBL2705851 0.72 ALDH1A1 (0.48) ALDH1A1HSD17B10LMNAGAAALOX15
SCHEMBL8914013 0.72 ALDH1A1 (0.48) ALDH1A1HSD17B10LMNAGAAALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2200440-B1 ANTIBACTERIAL AMIDE AND SULFONAMIDE SUBSTITUTED HETEROCYCLIC UREA COMPOUNDS CRESTONE INC (US) 2017-07-19 EP disclosed
US-8148380-B2 Antibacterial amide and sulfonamide substituted heterocyclic urea compounds CRESTONE, INC. (US) 2012-04-03 US disclosed
US-20120015941-A1 Antibacterial Amide and Sulfonamide Substituted Heterocyclic Urea Compounds CRESTONE, INC. (US) 2012-01-19 US disclosed
EP-2200440-A1 ANTIBACTERIAL AMIDE AND SULFONAMIDE SUBSTITUTED HETEROCYCLIC UREA COMPOUNDS Crestone, Inc. (US) 2010-06-30 EP disclosed
WO-2009015208-A1 ANTIBACTERIAL AMIDE AND SULFONAMIDE SUBSTITUTED HETEROCYCLIC UREA COMPOUNDS REPLIDYNE, INC. (US) 2009-01-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015941-A1 Antibacterial Amide and Sulfonamide Substituted Heterocyclic Urea Compounds NAAA, AADAC, RPSA ALDH1A1 2806/4885HSD17B10 3778/4885LMNA 4293/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.